Modeling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient‐derived induced pluripotent stem cells

Abstract

AbstractBackgroundLoss of function mutations in PCDH19 gene causes an X‐linked, infant‐onset clustering epilepsy, associated with intellectual disability and autistic features. The unique pattern of inheritance includes random X‐chromosome inactivation, which leads to pathological tissue mosaicism. Females carrying PCDH19 mutations are affected, while males have a normal phenotype. No cure is presently available for this disease.MethodsFibroblasts from a female patient carrying frameshift mutation were reprogrammed into human induced pluripotent stem cells (hiPSCs). To create a cell model of PCDH19‐clustering epilepsy (PCDH19‐CE) where both cell populations co‐exist, we created mosaic neurons by mixing wild‐type (WT) and mutated (mut) hiPSC clones, and differentiated them into mature neurons with overexpression of the transcriptional factor Neurogenin 2.ResultsWe generated functional neurons from patient‐derived iPSC using a rapid and efficient method of differentiation through overexpression of Neurogenin 2. Was revealed an accelerated maturation and higher arborisation in the mutated neurons, while the mosaic neurons showed the highest frequency of action potential firing and hyperexcitability features, compared to mutated and WT neurons.ConclusionsOur findings provide evidence that PCDH19 c.2133delG mutation affects proper metaphases with increased numbers of centrosomes in stem cells and accelerates neuronal maturation in premature cells. PCDH19 mosaic neurons showed elevated excitability, representing the situation in PCDH19‐CE brain. We suggest Ngn2 hiPSC‐derived PCDH19 neurons as an informative experimental tool for understanding the pathogenesis of PCDH19‐CE and a suitable approach for use in targeted drug screening strategies.